Multidimensional Characterization of Soft-Tissue Sarcomas with FUS-TFCP2 or EWSR1-TFCP2 Fusions
Julia Schöpf(German Cancer Research Center), Claudia Scholl(German Cancer Research Center)
Cited by 1
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Prognostic Impact of Minimal Residual Disease in<i>CBFB-MYH11</i>–Positive Acute Myeloid Leukemia
|Journal of Clinical Oncology|2010|136
Comparative analysis of KRAS codon 12, 13, 18, 61 and 117 mutations using human MCF10A isogenic cell lines
|Scientific Reports|2015|132
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions
|Nature Communications|2024|27